文献速递泌尿系感染男科与性医学

针刺治疗慢性前列腺炎/慢性盆腔疼痛综合征:随机假针刺对照试验

Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Sham Acupuncture Controlled Trial.
PubMed 文献 · J Urol · 2018-05-05

这项32周随机对照试验将68例18至50岁慢性前列腺炎/慢性盆腔疼痛综合征患者随机分为针刺组与假针刺组,比较8周治疗及24周随访效果。主要结局NIH-CPSI总分变化在第8、20、32周组间差异分别为-5.7、-6.7、-7.4(均p<0.001),均超过4分最小临床重要差异。结论认为针刺较假针刺有临床且持久的获益,但需更大样本随机对照试验验证。

要点

  • 针刺组NIH-CPSI总分改善在第8、20、32周均显著优于假针刺组,差异超过最小临床重要差异。
  • 第4周时两组NIH-CPSI疼痛与生活质量子量表及I-PSS无显著差异(均p>0.05)。
  • 其余次要结局针刺组均统计学优于假针刺组,但研究样本量较小需进一步验证。

核心结论

  • 针刺较假针刺对慢性前列腺炎/慢性盆腔疼痛综合征显示出临床且持久的获益。
  • 未来仍需更大样本量的随机对照试验进一步验证。

研究设计与样本

  • 32周随机、假针刺对照试验,8周治疗后再随访24周。
  • 共纳入68例18至50岁慢性前列腺炎/慢性盆腔疼痛综合征患者,纳入意向性治疗分析。
  • 参与者随机分配至针刺组或非侵入性假针刺组,两组基线特征可比。

主要发现

  • NIH-CPSI总分从基线至第8周的变化为主要结局,第8、20、32周组间差异分别为-5.7(95%CI -7.8至-3.7)、-6.7(95%CI -8.9至-4.5)、-7.4(95%CI -9.8至-5.1),各p<0.001。
  • 上述差异均大于4分的最小临床重要差异。
  • 第4周时两组NIH-CPSI疼痛与生活质量子量表评分及I-PSS均无显著差异(各p>0.05)。
  • 其余所有次要结局针刺组均统计学优于假针刺组。

关键数值与推荐

  • 主要结局为NIH-CPSI总分从基线至第8周的变化。
  • 次要结局包括NIH-CPSI子量表评分、疼痛严重程度、I-PSS、总体反应率与满意度评估。
  • 最小临床重要差异为4分。

临床怎么用

  • 对慢性前列腺炎/慢性盆腔疼痛综合征患者,针刺可作为较假针刺有临床获益的考虑选项。
  • 疗效在第8周显现并持续至第32周,但第4周时疼痛与生活质量子量表及I-PSS尚未见显著差异。
  • 需结合样本量较小的局限,与患者沟通时说明证据仍需更大样本试验确认。

局限性

  • 样本量较小,作者指出未来需更大样本量的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the effectiveness of acupuncture in patients with chronic prostatitis/chronic pelvic pain syndrome. MATERIALS AND METHODS: We performed this 32-week randomized, controlled trial with 8 weeks of treatment followed by 24 weeks of followup to compare acupuncture with sham acupuncture. Participants with chronic prostatitis/chronic pelvic pain syndrome were randomly assigned to acupuncture or noninvasive sham acupuncture. The primary outcome was the change in the NIH-CPSI (National Institutes of Health Chronic Prostatitis Symptom Index) total score from baseline to week 8. Secondary outcomes were the NIH-CPSI subscale scores, pain severity, the I-PSS (International Prostate Symptom Score), the global response rate and satisfaction assessment. RESULTS: A total of 68 participants 18 to 50 years old were enrolled and included in intent to treat analyses. Baseline characteristics were comparable in the 2 groups. The reduction in the NIH-CPSI total score differed significantly between the 2 groups at weeks 8, 20 and 32 with a difference of -5.7 (95% CI -7.8--3.7), -6.7 (95% CI -8.9--4.5) and -7.4 (95% CI -9.8--5.1), respectively (each p <0.001). All differences were greater than the 4-point minimal clinically important difference. No significant difference was found between the groups in NIH-CPSI pain and quality of life subscale scores or in I-PSS at week 4 (each p >0.05). For all other secondary outcomes the acupuncture group was statistically better than the sham acupuncture group. CONCLUSIONS: Acupuncture showed clinical and long-lasting benefits compared with sham acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Randomized controlled trials with larger sample sizes are needed in the future.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Qin Z, Zang Z, Zhou K, et al. Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Sham Acupuncture Controlled Trial. J Urol. 2018. PMID: 29733836. doi:10.1016/j.juro.2018.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。